²úÆ·ÖÐÐÄ
Å£Ö¬·¾Ã¸(Lipase£©ELISA¼ì²âÊÔ¼ÁºÐ
Å£Ö¬·¾ËáºÏ³Éø(FAS£©ELISA¼ì²âÊÔ¼ÁºÐ
Å£Ö×Áö»µËÀÒò×Ó¦Á(TNF-¦Á£©ELISA¼ì²âÊÔ¼ÁºÐ
Å£Ö÷Òª¼±ÐÔÆÚµ°°×(MAP£©ELISA¼ì²âÊÔ¼ÁºÐ
ţת»¯Éú³¤Òò×Ó¦Â1(TGF-¦Â1£©ELISA¼ì²âÊÔ¼ÁºÐ
ţϸС²¡¶¾(BPV£©ELISA¼ì²âÊÔ¼ÁºÐ
Å£ºô³¦¹Â²¡¶¾IIIÐÍ(Reo-3£©ELISA¼ì²âÊÔ¼ÁºÐ
Å£²¡¶¾ÐÔ¸¹Ðº(BVD£©ELISA¼ì²âÊÔ¼ÁºÐ
Å£¿ÚÌãÒß²¡¶¾(FMDV£©ELISA¼ì²âÊÔ¼ÁºÐ
Å£¶»²¡¶¾(CPV£©ELISA¼ì²âÊÔ¼ÁºÐ
ţϸÂÝÐýÌ岡¶¾(LEP£©ELISA¼ì²âÊÔ¼ÁºÐ
Å£¿ÚÌãÒßAÐÍ¿¹Ìå(FMD-A-Ab£©ELISA¼ì²âÊÔ¼ÁºÐ
Å£ÀÒµ°°×(CSN£©ELISA¼ì²âÊÔ¼ÁºÐ
Å£¼×»ùغÍèͪ(Methyltestosterone£©ELISA¼ì²âÊÔ¼ÁºÐ
Å£×éÖ¯¶àëÄ¿¹Ô(TPA£©ELISA¼ì²âÊÔ¼ÁºÐ
Å£×éÖ¯ÐÍÏËÈÜøԼ¤»î¼Á(t-PA£©ELISA¼ì²âÊÔ¼ÁºÐ
Å£ÈýÁ×ËáÏÙÜÕ(ATP£©ELISA¼ì²âÊÔ¼ÁºÐ
Å£¶þÁ×ËáÏÙÜÕ(ADP£©ELISA¼ì²âÊÔ¼ÁºÐ
Å£ÑÌõ£°·ÏÙàÑßʶþºËÜÕËáÁ×Ëá(NADPH£©ELISA¼ì²âÊÔ¼ÁºÐ
Å£ÑÌõ£°·ÏÙàÑßʶþºËÜÕËá(NAD£©ELISA¼ì²âÊÔ¼ÁºÐ
Ò³´Î9/15 ÿҳ20Ìõ ×ܹ²287Ìõ Ê×Ò³ÉÏÒ»Ò³ÏÂһҳβҳ
µÚ6Äê